.ANALYSIS EMPHASIZE.06 August 2024.
A sizable randomized regulated test with cisgender ladies highlights the difficulties of fidelity to a regular oral preexposure prophylaxis regiment and demonstrates that twice-yearly treatment of lenacapavir can preserve successful HIV deterrence amounts over 6 months.